share_log

HC Wainwright & Co. Reiterates Buy on Spero Therapeutics, Maintains $6 Price Target

HC Wainwright & Co. Reiterates Buy on Spero Therapeutics, Maintains $6 Price Target

HC Wainwright & Co.重申买入 Spero Therapeutics,维持6美元的目标股价
Benzinga ·  2023/07/20 06:40

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Spero Therapeutics (NASDAQ:SPRO) with a Buy and maintains $6 price target.

HC Wainwright & Co. 分析师Raghuram Selvaraju重申Spero Therapeutics(纳斯达克股票代码:SPRO)的买入,并维持6美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发